Composition:
1 capsule contains at least 10⁷ live acidophilic lactobacilli and a kefir polysaccharide - 0.4 mg.
The preparation is a mixture of microbial mass of live antagonistically active acidophilic lactobacilli and inactivated by heating kefir fungi containing, water-soluble polysaccharide, subjected to grinding, packaged in capsules, lyophilized in the culture medium. Pharmacodynamics
The therapeutic effect of Acipol® is determined by the live acidophilic lactobacilli and kefir polysaccharide contained in it.
According to the mechanism of action, Acipol® is a multifactorial therapeutic agent, has antagonistic activity against pathogenic and conditionally pathogenic microorganisms, has a corrective effect on the intestinal microflora, and increases the immunological reactivity of the body. PURPOSE. Prevention and treatment of diseases of the gastrointestinal tract, in children from 3 months of age and adults; in combination with traditional treatment.
Pharmacokinetics:
Data on the pharmacokinetics of the drug Acipol not provided Side effects Side effects with the use of Acipol in the recommended doses have not been established. Features of the sale Offered without a prescription
Special conditions:
Not suitable for use:
- a preparation whose integrity of the inner packaging is broken;
- a drug without labeling or with fuzzy labeling;
- a drug with altered physical properties (capsule shape is broken), in the presence of foreign inclusions;
- An expired drug.
Complaints about the drug should be sent to the State Research Institute for Standardization and Control of Medical Biological Preparations. L.A. Tarasevich and the address of the manufacturer.
Indications:
Dysbacteriosis and conditions leading to its development: • acute intestinal infections (dysentery, salmonellosis, rotavirus gastroenteritis, etc.); • chronic colitis, enterocolitis of infectious and non-infectious origin;
• long-term antibiotic therapy. Dysbacteriosis and weight loss associated with:
• active antibiotic therapy of purulent-septic diseases in infants;
• chronic, protracted, recurrent pathologies of the respiratory system (bronchitis, pneumonia, including pneumocystis);
• atopic dermatitis and other allergic manifestations.
Prevention of dysbiosis. • Increased overall body resistance.
Dermatitis, Bronchitis, Flatulence, Intestinal infections, Dysbiosis, After a course of antibiotic therapy, Colitis, Inflammation of the lungs
Contraindications:
hypersensitivity to the components of the drug. Drug interaction
Drug interaction Acipol not described
Dosage:
Capsules are used inside, without chewing, washed down with boiled water. The size of the daily dose and duration of treatment of patients is determined by the doctor depending on the age, severity and duration of the disease and the severity of dysbiosis. Children from 3 months to 3 years of age should take Acipol® with food 1 capsule 2-3 times a day, after opening the capsule and dissolving its contents in milk or boiled water. The remaining age groups and adults of Acipol® are prescribed 1 capsule 3-4 times a day 30 minutes before meals. In acute intestinal infections, the drug is prescribed for 5-8 days. Longer courses are prescribed in the treatment of children with weight loss due to the chronic course of diseases accompanied by dysbiosis. For preventive purposes, Acipol® is prescribed 1 capsule once a day for 10-15 days. Repeated courses are carried out no earlier than 1 month after the end of the previous treatment
Overdose:
Currently, no cases of overdose of Acipol have been reported.